The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes

FASEB Journal

Volumn 14, Issue 14, 2000, Pages 2237-2246

  Saurin, Adrian T ^a   Martin, Jody L ^a   Heads, Richard J ^a   Foley, Claire ^a   Mockridge, James W ^a   Wright, Matt J ^a   Wang, Yibin ^b   Marber, Michael S ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cardioprotection; Cytoprotection; Ischemic preconditioning; Myocardial ischemia

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CREATINE KINASE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; SYNAPTOPHYSIN;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; GENETIC TRANSFECTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REOXYGENATION; VIRUS INFECTION;

ANIMALIA;

EID: 0033748263     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.99-0671com     Document Type: Article

References (60)

1. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
2. Medical and cellular implications of stunning, hibernation and preconditioning. An NHLBI workshop
3. Cardioprotection from ischemic preconditioning is lost following prolonged reperfusion in the rabbit
4. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning
5. Ischemic preconditioning in isolated cells
6. 3 receptor involvement
7. Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor
8. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts
9. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C
10. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart
11. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts
12. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts
13. Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels
14. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase
15. Effects of protein kinase C inhibitors in in situ and isolated ischemic rabbit myocardium
16. Preconditioning of isolated rat heart is mediated by protein kinase C
17. Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium
18. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning
19. ATP-sensitive potassium channels and myocardial preconditioning
20. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart
21. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: Evidence for involvement of p38 MAPK
22. An inhibitor of p38 Mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia
23. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death
24. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart
25. 'Stress-responsive' mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium
26. Cardioprotection in an in vitro model of hypoxic preconditioning
27. A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death
28. Cultured neonatal rat heart cells can be preconditioned by ischemia, but not by heat shock. The role of stress proteins
29. The expression of constitutively active isotypes of protein kinase C to investigate preconditioning
30. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes
31. Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors
32. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor
33. Human ventricular myocytes in vitro exhibit both early and delayed preconditioning responses to simulated ischemia
34. Cell-type specificity of preconditioning in an in vitro model
35. Preconditioning human cardiomyocytes and endothelial cells
36. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia
37. Preconditioning of isolated rabbit cardiomyocytes: Induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor
38. Differential protection of primary rat cardiocytes by transfection of specific heat stress proteins
39. Efficient selection for high-expression transfectants with a novel eukaryotic vector
40. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury
41. Analysis of the role of protein kinase C-alpha, -epsilon, and -zeta in T cell activation
42. Classical, novel and atypical isoforms of PKC stimulate ANF- and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes
43. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b
44. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene
45. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b
46. Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector
47. Stimulation of the stress-activated mitogen-actirated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion [review; 108 refs]
48. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity
49. Role of p38 MAP kinase in myocardial stress
50. Pyridinyl imidazoIe inhibitors of p38 mitogen-activated protein kinase bind in the ATP site
51. 2-terminal kinase in ventricular muscle cells
52. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family
53. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocytes apoptosis and improves cardiac function after myocardial ischemia and reperfusion
54. An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia
55. Ischemic preconditioning triggers tyrosine kinase signaling: A potential role for MAPKAP kinase 2
56. A selective ε-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death
57. Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes
58. The p38-MAPK inhibitor. SB 2 03580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs)
59. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase
60. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor. SB 2 03580